Search for author "A. Michael Lincoff"
79 Results
- You have accessRestricted accessAdministration of Recombinant P-Selectin Glycoprotein Ligand Fc Fusion Protein Suppresses Inflammation and Neointimal Formation in Zucker Diabetic Rat ModelZhongmin Zhou, Marc S. Penn, Farhad Forudi, Xiaorong Zhou, Khaldoun Tarakji, Eric J. Topol, A. Michael Lincoff and Kai WangArteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:1598-1603, originally published August 8, 2002https://doi.org/10.1161/01.ATV.0000032676.20514.8F
- You have accessAdministration of Recombinant P-Selectin Glycoprotein Ligand Fc Fusion Protein Suppresses Inflammation and Neointimal Formation in Zucker Diabetic Rat ModelZhongmin Zhou, Marc S. Penn, Farhad Forudi, Xiaorong Zhou, Khaldoun Tarakji, Eric J. Topol, A. Michael Lincoff, Kai WangArteriosclerosis, Thrombosis, and Vascular Biology October 2002, 22 (10) 1598-1603; DOI: https://doi.org/10.1161/01.ATV.0000032676.20514.8FFigure 1. Photomicrographs of representative P-selectin immunostaining showing arteries fro...Show MoreFigure 1. Photomicrographs of representative P-selectin immunostaining showing arteries from control and rPSGL-treated rats at 1, 3, and 7 days after balloon injury. A, Section from rat at day 1 showed positive P-selectin immunostaining. B, Section from rat at day 3 showed P-selectin staining around lumen. C, By day 7, more intense P-selectin staining was observed around lumen and extending into media. D through F, Sections from days 1, 3, and 7 in rPSGL-Ig–treated rats, showing significantly decreased P-selectin expression.Show Less
- Table 1.You have accessAdministration of Recombinant P-Selectin Glycoprotein Ligand Fc Fusion Protein Suppresses Inflammation and Neointimal Formation in Zucker Diabetic Rat ModelZhongmin Zhou, Marc S. Penn, Farhad Forudi, Xiaorong Zhou, Khaldoun Tarakji, Eric J. Topol, A. Michael Lincoff, Kai WangArteriosclerosis, Thrombosis, and Vascular Biology October 2002, 22 (10) 1598-1603; DOI: https://doi.org/10.1161/01.ATV.0000032676.20514.8F
- You have accessAdministration of Recombinant P-Selectin Glycoprotein Ligand Fc Fusion Protein Suppresses Inflammation and Neointimal Formation in Zucker Diabetic Rat ModelZhongmin Zhou, Marc S. Penn, Farhad Forudi, Xiaorong Zhou, Khaldoun Tarakji, Eric J. Topol, A. Michael Lincoff, Kai WangArteriosclerosis, Thrombosis, and Vascular Biology October 2002, 22 (10) 1598-1603; DOI: https://doi.org/10.1161/01.ATV.0000032676.20514.8FFigure 2. Photomicrographs of representative CD45 immunostaining showing arteries from cont...Show MoreFigure 2. Photomicrographs of representative CD45 immunostaining showing arteries from control and rPSGL–treated rats at 1, 3, and 7 days after balloon injury. A, Section from control rat at day 1 showed intense CD45 immunostaining. B, Section from control rat at day 3 showed CD45 staining around lumen. C, By day 7, control rat sections still had intense CD45 staining, observed around lumen and extending into media. D through F, Much less CD45 immunostaining was observed in rPSGL–treated rat at days 1, 3, and 7.Show Less
- Table 2.You have accessAdministration of Recombinant P-Selectin Glycoprotein Ligand Fc Fusion Protein Suppresses Inflammation and Neointimal Formation in Zucker Diabetic Rat ModelZhongmin Zhou, Marc S. Penn, Farhad Forudi, Xiaorong Zhou, Khaldoun Tarakji, Eric J. Topol, A. Michael Lincoff, Kai WangArteriosclerosis, Thrombosis, and Vascular Biology October 2002, 22 (10) 1598-1603; DOI: https://doi.org/10.1161/01.ATV.0000032676.20514.8F
- Table 3.You have accessAdministration of Recombinant P-Selectin Glycoprotein Ligand Fc Fusion Protein Suppresses Inflammation and Neointimal Formation in Zucker Diabetic Rat ModelZhongmin Zhou, Marc S. Penn, Farhad Forudi, Xiaorong Zhou, Khaldoun Tarakji, Eric J. Topol, A. Michael Lincoff, Kai WangArteriosclerosis, Thrombosis, and Vascular Biology October 2002, 22 (10) 1598-1603; DOI: https://doi.org/10.1161/01.ATV.0000032676.20514.8F
- You have accessAdministration of Recombinant P-Selectin Glycoprotein Ligand Fc Fusion Protein Suppresses Inflammation and Neointimal Formation in Zucker Diabetic Rat ModelZhongmin Zhou, Marc S. Penn, Farhad Forudi, Xiaorong Zhou, Khaldoun Tarakji, Eric J. Topol, A. Michael Lincoff, Kai WangArteriosclerosis, Thrombosis, and Vascular Biology October 2002, 22 (10) 1598-1603; DOI: https://doi.org/10.1161/01.ATV.0000032676.20514.8FFigure 3. Photomicrographs of carotid arteries 21 days after balloon injury (Movat, ×5). A,...Show MoreFigure 3. Photomicrographs of carotid arteries 21 days after balloon injury (Movat, ×5). A, Representative light microscopy of cross section of injured carotid artery from rPSGL treatment group showing reduced neointimal hyperplasia with large luminal area. B, Representative light microscopy of cross section of injured carotid artery from control group showing extensive neointimal hyperplasia with smaller luminal area.Show Less
- You have accessRestricted accessAdministration of Recombinant P-Selectin Glycoprotein Ligand Fc Fusion Protein Suppresses Inflammation and Neointimal Formation in Zucker Diabetic Rat ModelZhongmin Zhou, Marc S. Penn, Farhad Forudi, Xiaorong Zhou, Khaldoun Tarakji, Eric J. Topol, A. Michael Lincoff and Kai WangArteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:1598-1603, originally published August 8, 2002https://doi.org/10.1161/01.ATV.0000032676.20514.8F
- You have accessAdministration of Recombinant P-Selectin Glycoprotein Ligand Fc Fusion Protein Suppresses Inflammation and Neointimal Formation in Zucker Diabetic Rat ModelZhongmin Zhou, Marc S. Penn, Farhad Forudi, Xiaorong Zhou, Khaldoun Tarakji, Eric J. Topol, A. Michael Lincoff, Kai WangArteriosclerosis, Thrombosis, and Vascular Biology October 2002, 22 (10) 1598-1603; DOI: https://doi.org/10.1161/01.ATV.0000032676.20514.8FFigure 1. Photomicrographs of representative P-selectin immunostaining showing arteries fro...Show MoreFigure 1. Photomicrographs of representative P-selectin immunostaining showing arteries from control and rPSGL-treated rats at 1, 3, and 7 days after balloon injury. A, Section from rat at day 1 showed positive P-selectin immunostaining. B, Section from rat at day 3 showed P-selectin staining around lumen. C, By day 7, more intense P-selectin staining was observed around lumen and extending into media. D through F, Sections from days 1, 3, and 7 in rPSGL-Ig–treated rats, showing significantly decreased P-selectin expression.Show Less
- Table 1.You have accessAdministration of Recombinant P-Selectin Glycoprotein Ligand Fc Fusion Protein Suppresses Inflammation and Neointimal Formation in Zucker Diabetic Rat ModelZhongmin Zhou, Marc S. Penn, Farhad Forudi, Xiaorong Zhou, Khaldoun Tarakji, Eric J. Topol, A. Michael Lincoff, Kai WangArteriosclerosis, Thrombosis, and Vascular Biology October 2002, 22 (10) 1598-1603; DOI: https://doi.org/10.1161/01.ATV.0000032676.20514.8F
Pages
Journal
Article Type
Article Type
- Acute coronary syndromes 5
- Antiplatelets 5
- Article 7
- Basic Science Reports 1
- Brief Rapid Communications 3
- Clinical Investigation and Reports 43
- Clinical Investigation and Reports* 1
- Growth factors/cytokines 7
- In Vitro 1
- Journal Article 2
- Other Vascular biology 7
- Other anticoagulants 5
- Research Support, Non-U.S. Gov't 1
- Research Support, U.S. Gov't, P.H.S. 1
- Review 2
- Thrombosis 10
- Type 2 diabetes 7
- Vascular Biology 14
Subject
Subject
- Acute coronary syndromes 20
- Acute myocardial infarction 4
- Animal models of human disease 1
- Anticoagulant mechanisms 9
- Antiplatelets 10
- Arterial thrombosis 8
- Cardiovascular Pharmacology 17
- Catheter-based coronary and valvular interventions: other 6
- Catheter-based coronary interventions: stents 8
- Chronic ischemic heart disease 8
- Coagulation 9
- Coagulation inhibitors 8
- Coronary imaging: angiography/ultrasound/Doppler/CC 2
- Growth factors/cytokines 14
- Health policy and outcome research 1
- Other Treatment 1
- Other Vascular biology 14
- Other anticoagulants 18
- Other diagnostic testing 1
- Pathophysiology 1
- Platelet function inhibitors 4
- Platelets 7
- Receptor pharmacology 1
- Restenosis 13
- Risk Factors for Stroke 1
- Secondary prevention 1
- Thrombin 8
- Type 2 diabetes 15
Content Type
Resource Type
- Articles 39
- Tables & Figures 29
- HWTABLE 11


